Peer-influenced content. Sources you trust. No registration required. This is HCN.
ReachMD
The mass in the young child’s head was a “malformed monochorionic diamniotic twin,” which means that the fetuses shared the same placenta but had separate amniotic sacs in the womb. The phenomenon of one fetus becoming enveloped by another is known as “fetus in fetu” (“parasitic twin”), and it occurs in approximately 1 in 500,000 live births. The malformed fetus usually appears as a mass in the abdomen of the other fetus, wedged behind the abdominal wall tissues. In this case, however, the mass appeared in the “host” fetus’s head and most likely arose very early in development.
Neurology March 22nd 2023
MDLinx
Some cans of Bumble Bee, Chicken of the Sea, StarKist, Safe Catch, and Wild Planet tuna contained higher than usual mercury levels, despite the average level being within standards.
All Specialties March 7th 2023
British Medical Journal (The BMJ)
Maternal immunization with 2 doses of vaccine was 97% and 53% effective against infant hospitalization from delta and omicron variants, respectively. The effectiveness of the vaccine in preventing infant hospitalization declined by nearly 20% after 16 weeks. Receiving the second dose in the third trimester yielded the greatest benefit.
Family Medicine/General Practice March 2nd 2023
Medical Professionals Reference (MPR)
Emzahh (norethindrone tablets), the progestin-only generic equivalent of the discontinued Ortho Micronor, was approved via an abbreviated NDA.
Internal Medicine February 15th 2023
Nursing in Practice
Researchers examined the OTC drug shopping patterns of 153 women before being diagnosed with ovarian cancer and compared them to the patterns seen in 120 women without ovarian cancer. Participants in the study also answered questions regarding the symptoms they had and the number of times they had seen their general practitioner in the year preceding a cancer referral or diagnosis. Eight months before diagnosis, there was a substantial difference in the OTC drug buying habits of women with and without ovarian cancer. Up to nine months prior to diagnosis, there was a rise in the purchasing of dyspepsia medications.
Clinical Pharmacology February 13th 2023
The modified Mifepristone Risk Evaluation and Mitigation Strategy (REMS) Program eliminates the requirement for in-person dispensing and replaces it with a requirement that pharmacies dispense the drug be certified. Mifepristone, a progestin antagonist, may now be dispensed by or under the supervision of a certified prescriber, or by a certified pharmacy on a prescription issued by a certified prescriber, for medical termination of pregnancy up to 10 weeks gestation (70 days or less since the first day of the last menstrual period).
Clinical Pharmacology January 30th 2023